U.S. Markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
18.17+0.20 (+1.11%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close17.97
Open17.95
Bid18.14 x 1100
Ask19.72 x 1200
Day's Range17.89 - 18.36
52 Week Range9.32 - 21.94
Volume121,353
Avg. Volume149,649
Market Cap744.296M
Beta (5Y Monthly)1.46
PE Ratio (TTM)N/A
EPS (TTM)-0.81
Earnings DateMar 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.88
  • We Think Xenon Pharmaceuticals (NASDAQ:XENE) Can Afford To Drive Business Growth
    Simply Wall St.

    We Think Xenon Pharmaceuticals (NASDAQ:XENE) Can Afford To Drive Business Growth

    Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

  • Xenon Pharmaceuticals Provides Corporate Update Following its Annual Meeting of Shareholders
    GlobeNewswire

    Xenon Pharmaceuticals Provides Corporate Update Following its Annual Meeting of Shareholders

    BURNABY, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, provided a corporate update following its 2021 Annual Meeting of Shareholders (the “Annual Meeting”) held today on June 3, 2021. Dr. Simon Pimstone, Executive Chair of Xenon’s Board of Directors stated, “We announced plans for a leadership transition earlier in the year, implemented a seamless succession plan, and effected these appointments at our

  • Xenon Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference
    GlobeNewswire

    Xenon Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference

    BURNABY, British Columbia, May 31, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced that members of its executive management team will participate in the following investor conference: Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021 at 3:00 pm ET. The live webcast of the fireside chat can be accessed here. The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon's website at investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event. About Xenon Pharmaceuticals Inc. We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com. “Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner. Contact:Maria McCleanXenon Pharmaceuticals Inc.Phone: 604.484.3353Email: investors@xenon-pharma.com